501
|
|
|
Nuclear receptor subfamily 1 group D member 2 |
BD73, EAR-1R, REVERBB, REVERBbeta, RVR |
|
502
|
|
|
Nuclear receptor subfamily 1 group H member 2 |
LXR-b, LXRB, NER, NER-I, RIP15, UNR |
|
503
|
|
|
Nuclear receptor subfamily 1 group H member 3 |
LXR-a, LXRA, RLD-1 |
Ischemic stroke, Cerebrovascular disorder, Cholelithiasis, Kidney disease, Clear cell renal cell carcinoma, Fatty liver, Fatty liver, alcoholic, Hypertension, Kidney failure, Major depressive disorder, Metabolic syndrome, Mood disorder, Multiple sclerosis, Myocardial infarction, Obesity, Diabetes mellitus type 2View all (1 more) |
504
|
|
|
Nuclear receptor subfamily 1 group H member 4 |
BAR, FXR, HRR-1, HRR1, PFIC5, RIP14 |
Atherosclerosis, Hepatocellular carcinoma, Cholelithiasis, Crohn disease, Extravasation of diagnostic and therapeutic materials, Fatty liver, Fatty liver, alcoholic, Hepatomegaly, Male infertility, Intestinal neoplasms, Intrahepatic cholestasis of pregnancy, Liver disease, Liver neoplasms, Necrosis, Nonalcoholic fatty liver disease, Non-small cell lung carcinoma, Progressive intrahepatic cholestasis, Squamous cell carcinomaView all (3 more) |
505
|
|
|
Nuclear receptor subfamily 1 group I member 2 |
BXR, ONR1, PAR, PAR1, PAR2, PARq, PRR, PXR, SAR, SXR |
Barrett esophagus, Calcinosis, Diabetes mellitus, Esophageal neoplasms, Fatty liver, Fatty liver, alcoholic, Hepatomegaly, Female infertility, Metabolic syndrome, Obesity, Osteosarcoma, Scoliosis |
506
|
|
|
Nuclear receptor subfamily 1 group I member 3 |
CAR, CAR1, MB67 |
|
507
|
|
|
Nuclear receptor subfamily 2 group C member 1 |
TR2 |
|
508
|
|
|
Nuclear receptor subfamily 2 group C member 2 |
TAK1, TR4 |
|
509
|
|
|
Nuclear receptor 2C2 associated protein |
TRA16 |
|
510
|
|
|
Nuclear receptor subfamily 2 group E member 1 |
TLL, TLX, XTLL |
|